Live Chat

交易 Novavax NVAX

Novavax實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
date 關閉 change 更改(%): 開倉

Markets.com news

N/A
2024 Dec 10, 16:00

中文的文章

man writing inflation on line charts
Alvaro Ramos 2024 Aug 07, 16:00

No English Content Dependency

2024 Jul 31, 16:00

测试标题

Volkswagen shares drop on overnight profit warning
Georgy Istigechev 2024 Jul 10, 10:45

Volkswagen shares slide as firm mulls Brussels plant closure (ZH-TW)

聯絡方式

點差

0.07

點差(%)

0.7609 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場開放

星期二

14:31 - 20:59

星期一

14:31-20:59

星期三

14:31-20:59

星期四

14:31-20:59

星期五

14:31-20:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

1383998336

流通股份

160184992

收益日期(下一個)

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

每股盈餘

-2.18

了解有關此金融工具的詳細資訊

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

相關金融工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot
Live Chat